Your browser doesn't support javascript.
loading
Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.
Kiluk, Brian D; Carroll, Kathleen M; Duhig, Amy; Falk, Daniel E; Kampman, Kyle; Lai, Shengan; Litten, Raye Z; McCann, David J; Montoya, Ivan D; Preston, Kenzie L; Skolnick, Phil; Weisner, Constance; Woody, George; Chandler, Redonna; Detke, Michael J; Dunn, Kelly; Dworkin, Robert H; Fertig, Joanne; Gewandter, Jennifer; Moeller, F Gerard; Ramey, Tatiana; Ryan, Megan; Silverman, Kenneth; Strain, Eric C.
Afiliação
  • Kiluk BD; Yale University School of Medicine, West Haven, CT 06516, USA. Electronic address: brian.kiluk@yale.edu.
  • Carroll KM; Yale University School of Medicine, West Haven, CT 06516, USA.
  • Duhig A; Xcenda, Palm Harbor, FL, USA.
  • Falk DE; National Institute on Alcohol Abuse and Alcoholism (NIAAA), Bethesda, MD, USA.
  • Kampman K; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Lai S; Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Litten RZ; National Institute on Alcohol Abuse and Alcoholism (NIAAA), Bethesda, MD, USA.
  • McCann DJ; National Institute on Drug Abuse (NIDA), Bethesda, MD, USA.
  • Montoya ID; National Institute on Drug Abuse (NIDA), Bethesda, MD, USA.
  • Preston KL; National Institute on Drug Abuse (NIDA), Bethesda, MD, USA.
  • Skolnick P; National Institute on Drug Abuse (NIDA), Bethesda, MD, USA.
  • Weisner C; Division of Research, Kaiser Permanente, University of California-San Francisco, San Francisco, CA, USA.
  • Woody G; University of Pennsylvania and Treatment Research Institute, Philadelphia, PA, USA.
  • Chandler R; National Institute on Drug Abuse (NIDA), Bethesda, MD, USA.
  • Detke MJ; Embera Neurotherapeutics, Indiana University School of Medicine, Carmel, IN, USA.
  • Dunn K; Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Dworkin RH; University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
  • Fertig J; National Institute on Alcohol Abuse and Alcoholism (NIAAA), Bethesda, MD, USA.
  • Gewandter J; University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
  • Moeller FG; Virginia Commonwealth University, Richmond, VA, USA.
  • Ramey T; National Institute on Drug Abuse (NIDA), Bethesda, MD, USA.
  • Ryan M; National Institute on Alcohol Abuse and Alcoholism (NIAAA), Bethesda, MD, USA.
  • Silverman K; Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Strain EC; Johns Hopkins School of Medicine, Baltimore, MD, USA.
Drug Alcohol Depend ; 158: 1-7, 2016 Jan 01.
Article em En | MEDLINE | ID: mdl-26652899
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Guias de Prática Clínica como Assunto / Congressos como Assunto / Transtornos Relacionados ao Uso de Substâncias / Estimulantes do Sistema Nervoso Central Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Drug Alcohol Depend Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Guias de Prática Clínica como Assunto / Congressos como Assunto / Transtornos Relacionados ao Uso de Substâncias / Estimulantes do Sistema Nervoso Central Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Drug Alcohol Depend Ano de publicação: 2016 Tipo de documento: Article